Fundación Pública Galega de Medicina Xenómica
Centro de investigación
![Foto de Fundación Pública Galega de Medicina Xenómica](/img/noimage.png)
![Foto de University of Montpellier](/img/noimage_org.png)
University of Montpellier
Montpellier, FranciaPublicacións en colaboración con investigadores/as de University of Montpellier (14)
2023
-
Comparison of prone and supine positioning for breast cancer radiotherapy using REQUITE data: dosimetry, acute and two years physician and patient-reported outcomes
Acta Oncologica, Vol. 62, Núm. 9, pp. 1036-1044
-
Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy
Breast, Vol. 72
2022
-
High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer
Frontiers in Oncology, Vol. 12
-
New insights into the genetic etiology of Alzheimer's disease and related dementias
Nature genetics, Vol. 54, Núm. 4, pp. 412-436
-
Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)
Lung Cancer, Vol. 166, pp. 228-241
-
Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort
eBioMedicine, Vol. 84
-
Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer
Radiotherapy and Oncology, Vol. 168, pp. 75-82
2021
-
A data science approach for early-stage prediction of Patient's susceptibility to acute side effects of advanced radiotherapy
Computers in Biology and Medicine, Vol. 135
2020
-
Genome wide association study of acute radiation toxicity and quality of life in breast cancer patients – results from the REQUITE cohort study
European Journal of Cancer, Vol. 138, pp. S12
2019
-
Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2)
Nature Genetics
-
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Nature Genetics, Vol. 51, Núm. 3, pp. 414-430
-
REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer
Radiotherapy and Oncology, Vol. 138, pp. 59-67
2015
-
Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export
Nature Genetics, Vol. 47, Núm. 6, pp. 579-581